Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VXX-001 by Viravaxx for Hepatitis B: Likelihood of Approval
VXX-001 is under clinical development by Viravaxx and currently in Phase II for Hepatitis B. According to GlobalData, Phase II...